| Identification | Back Directory | [Name]
HUMAN MIDKINE | [CAS]
170138-17-7 | [Synonyms]
MK
NEGF-2
TRICK2
MIDKINE
HUMAN MK
TRAIL-R2
HUMAN NEGF-2
HUMAN MIDKINE
MIDKINE mouse
MIDKINE, HUMAN
RECOMBINANT HUMAN MIDKINE
Midkine, human >=90% (SDS-PAGE)
heparin-binding growth/differentiation factor
Anti-Mevalonate Kinase antibody produced in rabbit
LYS-LYS-LYS-ASP-LYS-VAL-LYS-LYS-GLY-GLY-PRO-GLY-SER-GLU-CYS-ALA-GLU-TRP-ALA-TRP-GLY-PRO-CYS-THR-PRO-SER-SER-LYS-ASP-CYS-GLY-VAL-GLY-PHE-ARG-GLU-GLY-THR-CYS-GLY-ALA-GLN-THR-GLN-ARG-ILE-ARG-CYS-ARG-VAL-PRO-CYS-ASN-TRP-LYS-LYS-GLU-PHE-GLY-ALA-ASP-CYS-LYS-TYR-LYS-PHE-GLU-ASN-TRP-GLY-ALA-CYS-ASP-GLY-GLY-THR-GLY-THR-LYS-VAL-ARG-GLN-GLY-THR-LEU-LYS-LYS-ALA-ARG-TYR-ASN-ALA-GLN-CYS-GLN-GLU-THR-ILE-ARG-VAL-THR-LYS-PRO-CYS-THR-PRO-LYS-THR-LYS-ALA-LYS-ALA-LYS-ALA-LYS-LYS-GLY-LYS-GLY-LYS-ASP | [MDL Number]
MFCD00677322 |
| Hazard Information | Back Directory | [Biological Activity]
Midkinea heparin-binding growth factorcontains 121 amino acid residues with 5 disulfide bonds. It promotes the growthsurvivaland migration of various cellsand plays roles in neurogenesis and epithelial mesenchymal interactions during organogenesis. The C-terminal portion contains the heparin-binding domain and the antigenicity and neurite-promoting sequences. Both the C- and N-terminals are necessary for the moleculeμs neurotrophic effects. |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
ACROBiosystems
|
| Tel: |
18514007688 |
| Website: |
https://www.acrobiosystems.cn/?utm_source=chemical book&utm_medium=cpy&utm_campaign=chemical book official web site |
| Company Name: |
ZSGB-BIO
|
| Tel: |
02-400-810-9781 400810978 |
| Website: |
www.zsbio.com |
| Company Name: |
Merck KGaA
|
| Tel: |
(+86) 21 2033 8288 |
| Website: |
http://www.sigmaaldrich.cn |
| Company Name: |
|
| Tel: |
4001683301 |
| Website: |
www.beyotime.com |
|